Here is the backstory behind the 5,000% price hike of Daraprim. In Martin’s defense, the drug is classified as an ‘orphan drug‘, which means there is little demand due to the rarity of the underlying condition it is supposed to treat. In order for phrama companies to profit from orphan drugs, they have to charge… Continue reading The Daily View : Stocks Plunge, RIP American Dream, Why Prescription Drugs are so Expensive